Adverse events Number of events · participants with acute or subacute low‐back pain
It is very uncertain whether back school changes adverse events Number of events compared with combined myofascial therapy and joint manipulation (very low certainty).
1 finding from 1 review
All‐cause mortality · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in all‐cause mortality compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Stroke · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in stroke (total) compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Total coronary heart disease · general population including those at moderate to high risk of CVD, mean age between 30 and 75
Systematic screening showed no clear difference in coronary heart disease (total) compared with no/opportunistic screening (low certainty).
1 finding from 1 review
Cholesterol mg/dL · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Systolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Diastolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Mortality (all‐cause) · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (all‐cause) compared with any control treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (cardiovascular) compared with any control treatment (moderate certainty).
1 finding from 1 review
Myocardial infarction · any patient population and people with high cardiovascular risk
Colchicine probably leads to lower myocardial Infarction (total) compared with any control treatment (moderate certainty).
1 finding from 1 review
Adverse event (total) · any patient population and people with high cardiovascular risk
It is very uncertain whether colchicine changes adverse event (total) compared with any control treatment (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · any patient population and people with high cardiovascular risk
Colchicine may leads to higher adverse event (gastrointestinal) compared with any control treatment (low certainty).
1 finding from 1 review
Adverse event (serious) · any patient population and people with high cardiovascular risk
1 finding from 1 review
Heart failure · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in heart failure (total) compared with any control treatment (low certainty).
1 finding from 1 review
Stroke · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in stroke (total) compared with any control treatment (low certainty).
1 finding from 1 review
Intervention not reported
Incident dementia ‐ not measured · adults with cognitive impairment/dementia and cognitively intact populations
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cognition (at 90 days): t‐MMSE score1 · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Intervention not reported
Composite cognitive function6 (change over 16 weeks) · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Intervention not reported
Mortality (at 3 to 4 months' · adults with cognitive impairment/dementia and cognitively intact populations
The intervention showed no clear difference in mortality (at 3 to 4 months' (moderate certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular events (at 3 to 4 months' · adults with cognitive impairment/dementia and cognitively intact populations
The intervention showed no clear difference in cardiovascular events (at 3 to 4 months' (low certainty).
1 finding from 1 review